Midostaurin (Rydapt ®)

Midostaurin (Rydapt ®)
Product Description

Indication: Acute myeloid leukemia. Aggressive systemic mastocytosis - Under Development

Cyndea Pharma S.L

  • ES
  • 2015
    On CPHI since
  • 5
    Certificates
  • 500 - 999
    Employees
Company types
Manufacturer/Innovator

Cyndea Pharma S.L

  • ES
  • 2015
    On CPHI since
  • 5
    Certificates
  • 500 - 999
    Employees
Company types
Manufacturer/Innovator

More Products from Cyndea Pharma S.L (16)